The COVID-19 pandemic necessitates rapid research to characterize SARS-CoV-2, understand host-pathogen interactions, and develop functional vaccines and therapeutics. Scientists working on this problem use innovative technologies to study molecular interactions essential for viral infection, which then guides drug and vaccine development. In this webinar sponsored by Sartorius, Dmitri Svergun, Pedro Beltrao, and Christian Loew will discuss how they fast-track COVID-19 virology research by identifying molecular targets and assessing their structure and function for antiviral therapies.
Topics to be covered
Studying the cellular processes targeted by SARS-CoV-2 to identify potential antiviral drugs
Structural analysis of COVID-19-related molecules by small-angle X-ray scattering
Selection and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2
Thursday, March 25, 2021
9:00 - 11:00 AM Eastern Time (2:00 - 4:00 PM CET)
Pedro Beltrao, PhD Group Leader European Molecular Biology Laboratory (EMBL) European Bioinformatics Institute (EMBL-EBI) Wellcome Genome Campus, Cambridge, UK
Dmitri Svergun, PhD Group Leader and Senior Scientist European Molecular Biology Laboratory (EMBL), Hamburg Unit Deutsches Elektronen Synchrotron (DESY)
Christian Löw, PhD Group Leader European Molecular Biology Laboratory (EMBL), Hamburg Unit Deutsches Elektronen Synchrotron (DESY)
Fast-Tracking COVID-19 Research
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
The Scientist c/o LabX Media Group 1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll Free: 888.788.0328 | Phone: 705.528.6888 Email: email@example.com